A dominant negative mutant of jun blocking 12-O-tetradecanoylphorbol- 13-acetate-induced invasion in mouse keratinocytes

Molecular Carcinogenesis

Volumn 19, Issue 3, 1997, Pages 204-212

  Dong, Zigang ^a,c   Crawford, Howard C ^b   Lavrovsky, Vadim ^a   Taub, Dennis ^a   Watts, Rebecca ^a   Matrisian, Lynn M ^b   Colburn, Nancy H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

12 O tetradecanoylphorbol 13 acetate; Activator protein 1; Metalloproteinases; Neoplastic progression

Indexed keywords

COLLAGENASE; CYTOKERATIN 14; GELATINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRIX METALLOPROTEINASE; PHORBOL 13 ACETATE 12 MYRISTATE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL INVASION; CELL TRANSFORMATION; CONTROLLED STUDY; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; TRANSCRIPTION REGULATION; TUMOR PROMOTION;

ANIMALS; ANTICARCINOGENIC AGENTS; CARCINOGENS; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; GLYCOPROTEINS; KERATINOCYTES; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; MICE; MUTATION; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-JUN; RNA, MESSENGER; TETRADECANOYLPHORBOL ACETATE; TISSUE INHIBITOR OF METALLOPROTEINASES; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR AP-1; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA; MUS MUSCULUS;

EID: 0030749569     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199707)19:3<204::AID-MC8>3.0.CO;2-D     Document Type: Article

References (51)

1. Reznikoff CA, Brankow JS, Heidelberger C. Establishment and characterization of a cloned line of C3H mouse embryo cells sensitive to postconfluence inhibition of division. Cancer Res 33:3231-3238, 1973.
2. Mondal S, Heidelberger C. Transformation of C3H/10T1/2 CL8 mouse embryo fibroblasts by ultraviolet irradiation and a phorbol ester. Nature 260:710-711, 1976.
3. Sivak A, Tu AS. Cell culture tumor promotion experiments with saccharin, phorbol myristate acetate and several common food materials. Cancer Lett 10:27-32, 1980.
4. Berwald Y, Sachs L. In vitro transformation of normal cells to tumor cells by carcinogenic hydrocarbons. J Natl Cancer Inst 35:641-661, 1965.
5. Mondal S, Brankow DW, Heidelberger C. Two-stage chemical oncogenesis in cultures of C3H/10T1/2 cells. Cancer Res 36:2254-2260, 1976.
6. Dong Z, Birrer MJ, Watts RG, Matrisian LM, Colburn NH. Blocking tumor promoter induced AP-1 activity inhibits induced transformation in JB6 cells. Proc Natl Acad Sci USA 91:609-613, 1994.
7. Colburn NH, Former BF, Nelson KA, Yuspa SH. Tumor promoter induces anchorage independence irreversibly. Nature 281:589-591, 1979.
8. Colburn NH, Wendel E, Srinivas L. Responses of preneoplastic epidermal cells to tumor promoters and growth factors: Use of promoter-resistant variants for mechanism studies. J Cell Biochem 18:261-270, 1982.
9. Dong Z, Lavrovsky V, Colburn NH. Transformation reversion induced in JB6 RT101 cells by AP-1 inhibitors. Carcinogenesis 16:749-756, 1995.
10. Dong Z, Cmarik JL, Wendel EJ, Colburn NH. Differential transformation efficiency but not AP-1 induction under anchorage-dependent and -independent conditions. Carcinogenesis 15:1001-1004, 1994.
11. Dong Z, Colburn NH. AP-1 : A molecular target for prevention of carcinogenesis. In: Srivastava S, Lippman SM, Hong WK, Mulshine JL (eds), Early Detection of Cancer: Molecular Markers. Futura Press, Armonk, New York, 1994, pp. 123-130.
12. Nicholson RC, Mader S, Nagpal S, Leid M, Rochette-Egly C, Chambon P. Negative regulation of the rat stromelysin gene promoter by retinoic acid is mediated by an AP1 binding site. EMBO J 9:4443-4454, 1990.
13. Pfahl M. Nuclear receptor/AP-1 interaction. Endocrine Rev 14:651-658, 1993.
14. Li J-J, Dong Z, Dawson MI, Colburn NH. Inhibition of tumor promoter-induced transformation by retinoids that transrepress AP-1 without transactivating retinoic acid response element. Cancer Res 56:483-489, 1996.
15. Strickland JE, Greenhalgh DA, Koceva-Chyla A, et al. Development of murine epidermal cell lines which contain an activated ras-Ha oncogene and form papillomas in skin grafts on athymic nude mouse hosts. Cancer Res 48:165-169, 1988.
16. Hennings H, Lowry DT, Robinson A, Morgan DL, Kujiki H, Yuspa SH. Activity of diverse tumor promoters in a keratinocyte co-culture model of initiated epidermis. Carcinogenesis 11:2145-2151, 1992.
17. Greenhalgh DA, Yuspa SH. Malignant conversion of murine squamous papillonna cell lines by transfection with the fos oncogene. Mol Carcinog 1:134-143, 1988.
18. Hennings H, Robinson VA, Michael DM, Pettit GR, Jung R, Yuspa SH. Development of an in vitro analogue of initiated mouse epidermis to study tumor promoters and antipromoters. Cancer Res 50:4794-4800, 1990.
19. Birkedal-Hansen H, Moore WGI, Bodden MK, et al. Matrix metalloproteinases: A review. Crit Rev Oral Biol Med 4:197-250, 1993.
20. Stetler-Stevenson WG, Aznavoorian S, Liotta LA. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 9:549-573, 1993.
21. Matrisian LM. Matrix metalloproteinase gene expression. Ann NY Acad Sci 732:42-50, 1994.
22. Angel P, Imagawa M, Chiu R, Stein B, Imbra RJ, Rahmsdorf HJ. Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor. Cell 49:729-739, 1987.
23. Matrisian LM, Leroy P, Ruhlmann C, Gesnel M-C, Breathnach R. Isolation of the oncogene and epidermal growth factor-induced transin gene: Complex control in rat fibroblasts. Mol Cell Biol 6:1679-1686, 1986.
24. Kerr LD, Holt JT, Matrisian LM. Growth factors regulate transin gene expression by c-fos-dependent and c-fos-independent pathways. Science 242:1424-1427, 1988.
25. Stein B, Baldwin AS, Ballard DW, Greene WC, Angel P, Herrlich P. Cross-coupling of the NF-KB p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J 12:3879-3891, 1993.
26. Witty JP, McDonnell S, Newell KJ, et al. Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo. Cancer Res 54:4805-4812, 1994.
27. Carroll R, Martarano L, Derse D. Identification of lentivirus tat functional domains through generation of equine infectious anemia virus/human immunodeficiency virus type 1 tat gene chimeras. J Virol 65:3460-3467, 1991.
28. Witty JP, Wright JH, Matrisian LM. Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misregulation of stromelysin-1 in transgenic mice induces unscheduled alveolar development. Mol Biol Cell 6:1287-1303, 1995.
29. Gack S, Vallon R, Schaper J, Ruther U, Angel P. Phenotypic alterations in Fos-transgenic mice correlate with changes in Fos/Jun-dependent collagenase type I expression. Regulation of mouse metalloproteinases by carcinogens, tumor promoters, cAMP, and Fos oncoprotein. J Biol Chem 269:10363-10369, 1994.
30. Basset P, Bellocq JP, Wolf C, et al. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348:699-704, 1990.
31. Henriet P, Rousseau GG, Eeckhout Y. Cloning and sequencing of mouse collagenase cDNA: Divergence of mouse and rat collagenases from the other mammalian collagenases. FEBS Lett 310:175-178, 1992.
32. Reponen P, Sahlberg C, Huntala P, Hurskainen T, Thesleff I, Tryggvason K. Molecular cloning of murine 72-kDa type IV collagenase and its expression during mouse development. J Biol Chem 267:7856-7862, 1992.
33. Tanaka H, Hojo K, Yoshida H, Yoshioka T, Sugita K. Molecular cloning and expression of the mouse 105-kDa gelatinase cDNA. Biochem Biophys Res Commun 190:732-740, 1993.
34. Edwards DR, Waterhouse P, Holman ML, Denhardt DT. A growthresponsive gene (16C8) in normal mouse fibroblasts homologous to a human collagenase inhibitor with erythroid-potentiating activity: Evidence for constitutive and inducible transcripts. Nucleic Acids Res 14:8863-8878, 1986.
35. Okada A, Bellocq J-P, Rouyer N, et al. Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc Natl Acad Sci USA 92:2730-2734, 1995.
36. Cheng J, Turksen K, Yu Q-C, Schreiber H, Teng M, Fuchs E. Cachexia and graft-vs.-host-disease-type skin changes in keratin promoter-driven TNFα transgenic mice. Genes Dev 6:1444-1456, 1992.
37. Vassar R, Fuchs E. Transgenic mice provide new insights into the role of TGF-α during epidermal development and differentiation. Genes Dev 5:714-727, 1991.
38. Domann FE, Levy JP, Birrer MJ, Bowden GT. Stable expression of a c-jun deletion mutant in two malignant mouse epidermal cell lines blocks cellular AP-1 activity and tumor formation in nude mice. Cell Growth Differ 5:9-16, 1994.
39. Brown PH, Sanders DA, Alani R, Birrer MJ. Suppression of oncogene-mduced transformation by a deletion mutant of c-jun. Oncogene 8:877-886, 1992.
40. Tsang TC, Chu Y-W, Powell MB, et al. v-jun oncogene suppresses both phorbol ester-induced cell invasion and stromelysin gene expression in a mouse papilloma cell line. Cancer Res 54:882-886, 1994.
41. McDonnell SE, Kerr LD, Matrisian LM. Epidermal growth factor stimulation of stromelysin mRNA in rat fibroblasts requires induction of proto-oncogenes c-fos and c-jun and activation of protein kinase C. Mol Cell Biol 10:4284-4293, 1990.
42. Angel P, Hattori K, Smeal T, Karin M. The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1. Cell 55:875-885, 1988.
43. Angel P, Poting A, Mallick U, Rahmsdorf HJ, Schorpp M, Herrlich P. Induction of metallothionein and other mRNA species by carcinogens and tumor promoters in primary human skin fibroblasts. Mol Cell Biol 6:1760-1766, 1986.
44. Wasylyk C, Imler JL, Perez-Mutul J, Wasylyk B. The c-Ha-ras oncogene and a tumor promoter activate the polyoma virus enhancer. Cell 48:525-534, 1987.
45. Imbra RJ, Karin M. Phorbol ester induces the transcriptional stimulatory activity of the SV40 enhancer. Nature 323:555-558, 1986.
46. Sato H, Takino T, Okada Y, et al. A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 370:61-64, 1994.
47. Knauper V, Will H, Lopez-Otin C, et al. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1 -MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme. J Biol Chem 271:17124-17131, 1996.
48. Crawford HC, Matrisian LM. Mechanisms controlling the transcription of matrix metalloproteinase genes in normal and neoplastic cells. Enzyme Protein 49:20-37, 1996.
49. Voraberger G, Schafer R, Stratowa C. Cloning of the human gene for intracellular adhesion molecule 1 and analysis of its 5′-regulatory region. J Immunol 147:2777-2786, 1991.
50. Johnson JP, Rothbacher U, Sers C. The progression associated antigen MUC 18: A unique member of the immunoglobulin supergene family. Melanoma Res 3:337-340, 1993.
51. Hofmann M, Rudy W, Gunthert U, et al. Cloning and sequencing of mouse collagenase cDNA. A link between ras and metastatic behavior of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells. Cancer Res 53:1516-1521, 1993.